| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 8 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | Canada | 3 | |
| #4 | EPO (European Patent Office) | 3 | |
| #5 | Australia | 1 | |
| #6 | China | 1 | |
| #7 | Denmark | 1 | |
| #8 | Israel | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Machines | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Unspecified technologies | |
| #4 | Therapeutic chemical compounds | |
| #5 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Rodman Toby C | 17 |
| #2 | Bristow Cynthia | 2 |
| #3 | Bristow Cynthia L | 1 |
| #4 | Rodman T C | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2013017601A1 | Modulation of plasma membrane human leukocyte elastase | |
| US2008009442A1 | Therapeutic use for alpha1 proteinase inhibitor in hematopoiesis | |
| US6391635B1 | Monoclonal human natural antibodies | |
| US6610833B1 | Monoclonal human natural antibodies | |
| AU4116093A | Natural human igm antibodies | |
| US5606026A | Natural human IgM antibodies immunoreactive with the Tat protein of HIV-1 | |
| CA1340982C | Protamine-reactive igm antibodies |